Key Highlights

  • INLIF Limited (NASDAQ:INLF) changed hands at USD 0.4267 on November 12, 2026, a 39.03% fall, with roughly 5.57 million shares traded, after dropping close to 22% in extended trading the night before.
  • On November 11, a Subsidiary revealed a three-year procurement and Supply arrangement with Heng Sheng Group worth a planned USD 30 million, and shares climbed more than 27% that day.
  • The sums are provisional rather than minimum purchase requirements and are split into six stages of roughly USD 5 million apiece.
  • October's stock and pre-funded Warrant sale raised about USD 3.75 million at USD 1.60 per unit, and those warrants include a one-time exercise price reset.

A Headline Surge That Failed to Last

INLIF Limited (NASDAQ:INLF) manufactures manipulator arms for injection molding equipment, plus automation and testing machinery for lithium battery and energy storage makers, all through its Chinese subsidiary. It moved into humanoid robotics in June. Early on November 11 the subsidiary concluded a multi-year supply arrangement with Heng Sheng Group, valued at USD 30 million across three years and divided into six roughly USD 5 million tranches every half year. Shares opened near USD 0.88 versus a previous close of about USD 0.55, peaking at USD 0.96. The advance faded during the session, the stock lost about 22% after hours, and it fell another 39.03% on November 12. The framework states that its figures are preliminary and not minimum commitments, which probably capped the value traders assigned to it, though no company statement accounts for the drop.

Dilution Overhang From the October Financing

Share supply adds further pressure. On October 19 the company priced a registered direct offering of roughly USD 3.75 million, comprising 435,000 Class A shares plus pre-funded warrants for up to 1,908,750 shares at USD 1.60, each paired with Series A, B and C warrants. Series A and B warrants, each covering as many as 2,343,750 shares, reset their exercise price once, on the 20th trading day after issuance, which could reduce the price at which new shares get created when the stock is weak. In September shareholders endorsed raising authorized Capital to 8 billion Class A shares, and a 1-for-200 share combination became effective in July. With the stock well under the October offering price, traders likely expect more issuance, an inference rather than a disclosed reason.

Financial Results Stronger Than the Share Price Suggests

The reported figures paint a healthier picture than the quote does. For the six months ended June 30, 2026, Revenue grew 26.01% to USD 12.94 million, gross Margin reached 35.95%, and Net Income of USD 1.01 million replaced a year-earlier loss. Cash climbed to USD 45.47 million at June 30 from USD 6.72 million at the close of 2025, helped by USD 56.25 million of financing inflows. Still, the screen lists trailing diluted losses of USD 577.64 per share, a number skewed by the share combination, and a Market Value near USD 650,840. Relative Volume of only 0.04 highlights how unusual recent trading has been. Investors should monitor whether the first USD 5 million Tranche turns into actual orders, where the warrant reset lands, and whether Nasdaq bid price compliance can be restored with the shares below USD 1.00.

Where Things Stand

INLIF Limited (NASDAQ:INLF) dropped 39.03% to USD 0.4267 on November 12, 2026, as a rally tied to its USD 30 million Heng Sheng arrangement unwound. The deal is non-binding in dollar terms, and warrant resets from the October raise add dilution risk. First-half profit and cash look sound, so real orders and share issuance will shape the next move.